Answers are grounded in this paper and cite their sources.
Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS.
No takes yet. Share an insight, caveat, or question.
Boyle et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: